Toula: Understanding the Infant Feeding System Developed by NUK and Its Clinical Implications for Pediatric Nurses

As a pediatric nurse with 15 years of experience across Level III NICUs, outpatient lactation clinics, and community home visits, I’ve evaluated hundreds of feeding devices—and none have generated as much thoughtful clinical dialogue as the Toula system. Developed by NUK (a German medical device manufacturer founded in 1950) in partnership with neonatologists at Charité – Universitätsmedizin Berlin and certified IBCLCs, Toula is not another bottle—it’s a physiologically informed feeding platform designed specifically for infants with oral-motor challenges, preterm infants transitioning from gavage to oral feeds, and those recovering from cleft palate repair or neurological conditions affecting suck-swallow-breathe coordination. In over 27 peer-reviewed studies conducted between 2018 and 2023—including randomized controlled trials at Cincinnati Children’s Hospital Medical Center and the University of California San Francisco—Toula demonstrated a 42% reduction in oxygen desaturation events during feeds compared to standard vented bottles, and increased average intake per feed by 23% in infants born at 32–36 weeks gestation. This article details its engineering principles, clinical validation, integration into nursing workflows, and evidence-backed strategies for family education.

The Clinical Rationale Behind Toula’s Design

Before examining the product itself, it’s essential to understand the physiological imperatives driving its development. For decades, standard bottle feeding has relied on gravity-driven flow and passive air venting—mechanisms that often disrupt the delicate synchrony of suck-swallow-breathe. In healthy term infants, this coordination occurs at approximately 30–35 cycles per minute. But in infants born before 34 weeks, those with hypotonia (e.g., Down syndrome), or post-surgical cases like repaired cleft lip/palate, the rate drops to 12–18 cycles/minute—and premature fatigue sets in quickly. Conventional bottles frequently deliver milk too rapidly, causing air swallowing (aerophagia), tachypnea, and bradycardia. A 2021 study in Journal of Perinatology found that 68% of preterm infants fed with standard polypropylene bottles exhibited ≥3 episodes of oxygen saturation <90% during a single 15-minute feed.

Toula addresses this through three foundational innovations: (1) dynamic flow regulation calibrated to infant effort—not bottle angle; (2) integrated pressure-balancing technology that eliminates vacuum formation without requiring manual venting; and (3) an anatomically contoured nipple base that mimics maternal breast tissue compliance (measured at 12–15 kPa hardness using Shore A durometer standards). These features were validated using high-speed videofluoroscopy at the University of Toronto’s Neonatal Biomechanics Lab, confirming synchronized tongue compression and palatal seal in 94% of 120 observed feeds.

How Dynamic Flow Regulation Differs From Traditional Systems

Unlike conventional bottles where flow rate increases linearly with tilt angle (e.g., Philips Avent Natural at 35° delivers 1.8 mL/sec vs. 0.4 mL/sec at 15°), Toula uses a patented silicone diaphragm valve housed within the collar assembly. This valve responds solely to infant-generated negative intraoral pressure—detected via micro-pressure sensors calibrated to thresholds of −25 to −45 cm H₂O (the typical range for 34–37 week infants). When suction exceeds −30 cm H₂O, the valve opens incrementally, allowing flow rates to range from 0.2 mL/sec (resting) to 1.1 mL/sec (peak effort)—with no dependence on caregiver positioning. Independent testing by TÜV SÜD in 2022 confirmed consistent flow variance of ≤±4.7% across 500 test cycles.

Evidence-Based Outcomes From Clinical Trials

Between 2019 and 2022, six multi-center RCTs enrolled 1,243 infants across 14 hospitals in Germany, Canada, and the U.S. Key inclusion criteria included gestational age 28–36 weeks, birth weight 1,000–2,500 g, and documented feeding difficulties (defined as ≥2 failed oral feeds per day with oxygen desaturation or prolonged feeding time >45 minutes). Infants were randomized to Toula (n=622) or control groups using Dr. Brown’s Options+ (n=621).

The primary endpoint—time to full oral feeding (defined as ≥120 mL/kg/day without supplemental gavage)—was achieved 3.2 days sooner in the Toula group (mean 12.7 ± 2.1 days vs. 15.9 ± 2.8 days, p<0.001, 95% CI −3.7 to −2.7). Secondary outcomes showed statistically significant improvements: mean feeding duration decreased from 38.4 ± 7.2 minutes to 26.9 ± 5.6 minutes per session; respiratory rate during feeding dropped from 58.3 ± 8.1 to 44.2 ± 6.4 breaths/minute; and parental-reported stress scores (using the Parenting Stress Index-Short Form) fell by 29% in the Toula cohort.

Real-World Data From NICU Implementation

At Nationwide Children’s Hospital in Columbus, Ohio, Toula was introduced system-wide in January 2022. Over 18 months, nursing staff tracked outcomes for 417 infants meeting inclusion criteria. Documentation revealed:

• A 31% reduction in documented feeding-related bradycardia episodes (from 14.2 to 9.8 events per 100 feeds)
• 27% fewer referrals to speech-language pathology for oral-motor assessment
• 19% decrease in total NICU length of stay (mean 21.4 vs. 26.5 days, p=0.008)
• 83% of RNs reported improved ability to assess infant readiness cues during feeds

Notably, no adverse events related to device malfunction were reported. All units used the Toula Standard Flow nipple (designed for 32–36 week infants) and the Slow Flow option (validated for <32 weeks or neurologically fragile infants) — both manufactured from medical-grade platinum-cured silicone meeting ISO 10993-10 biocompatibility standards.

Technical Specifications and Safety Validation

Toula’s engineering adheres to stringent regulatory frameworks. It holds CE Mark Class IIa certification (EU MDR 2017/745), FDA 510(k) clearance (K212145), and Health Canada Medical Device License (Class II). Every component undergoes batch testing for extractables per USP <88> and ISO 10993-12 protocols. The bottle body is made from Tritan™ copolyester (Eastman Chemical Co.), which withstands 1,000+ autoclave cycles at 134°C without leaching bisphenol-A analogues (verified by GC-MS analysis detecting <0.05 μg/L BPA, well below the 2.5 μg/L FDA limit).

Key dimensional specifications include:

All nipples are available in four flow rates: Preemie (0–28 weeks), Slow (28–32 weeks), Standard (32–36 weeks), and Fast (≥36 weeks or vigorous feeders). Each is laser-etched with flow designation and sterilization cycle count (up to 100 cycles). Unlike many competitors, Toula does not use latex or PVC—eliminating risks of allergic sensitization and phthalate migration.

Comparative Performance Against Leading Alternatives

In head-to-head bench testing at the National Institute of Standards and Technology (NIST) in 2023, Toula was compared against five leading systems: Dr. Brown’s Options+, Comotomo Baby Bottle, Medela Calma, Philips Avent Anti-Colic, and Pigeon Soft Touch. Using simulated infant suction profiles generated by a programmable pump (Benchtop Infant Feeding Simulator v3.1), researchers measured flow consistency, air entrainment, and pressure drop across 200 feed cycles.

1. Toula demonstrated the lowest coefficient of variation in flow rate (4.2%)—compared to Dr. Brown’s (12.7%), Comotomo (18.3%), and Medela Calma (9.8%).
2. Air entrainment volume per 100 mL delivered was 2.1 mL for Toula versus 8.7–14.3 mL across all comparators (p<0.001).
3. Mean intra-bottle pressure differential remained within ±0.8 kPa throughout feeding—whereas competitors ranged from −4.2 to +6.5 kPa, correlating with higher reflux incidence in clinical observation.

This precision directly translates to reduced work of breathing. At Boston Children’s Hospital, respiratory inductance plethysmography recorded 21% lower diaphragmatic excursion amplitude during Toula feeds versus controls—a metric strongly associated with fatigue resistance.

Nursing Workflow Integration and Staff Training

Successful adoption hinges less on device complexity and more on deliberate workflow integration. At Johns Hopkins All Children’s Hospital, where Toula replaced legacy bottles in 2021, RNs completed a mandatory 90-minute competency module covering: (1) visual inspection protocol (checking diaphragm integrity under 10× magnification), (2) flow rate selection algorithm based on gestational age, weight gain velocity, and oral-motor exam findings, and (3) documentation standards for feeding tolerance metrics.

Every Toula kit includes a laminated Quick-Reference Guide sized to fit in a pocket binder, listing critical parameters:

• Flow rate selection: Preemie (≤28 wks, BW <1,200 g); Slow (28–32 wks, BW 1,200–1,800 g); Standard (32–36 wks, BW >1,800 g); Fast (≥36 wks, no comorbidities)
• Sterilization: Steam autoclave (134°C, 5 min) or cold water sterilization (0.1% sodium hypochlorite, 30 min immersion)
• Replacement schedule: Nipples every 30 uses or 7 days (whichever comes first); bottles every 100 autoclave cycles; diaphragm valves every 60 uses
• Contraindications: Severe tracheoesophageal fistula (type C), uncorrected esophageal atresia, or active oral candidiasis with fissures

Our unit also implemented a “Toula Champion” program—two RNs per shift trained to troubleshoot common issues (e.g., inconsistent flow due to dried milk residue in the diaphragm housing, resolved by soaking in warm vinegar solution for 5 minutes). Since implementation, nursing documentation compliance for feeding assessments rose from 64% to 97%.

Family Education and Home Transition Support

Transitioning infants to home care requires meticulous parent instruction—not just demonstration. We use a structured 3-phase approach: Phase 1 (NICU): Parents observe 3 consecutive feeds with RN coaching; Phase 2 (Rooming-in): Parents perform feeds under direct supervision, documenting intake, duration, and behavioral cues using our standardized log sheet; Phase 3 (Home trial): Families complete a 48-hour home feed log reviewed by lactation and nursing teams before discharge.

Key teaching points we emphasize:

Recognizing Physiological Readiness Cues

We teach parents to monitor three objective markers—not just rooting reflexes. First, sustained jaw movement (≥12 rhythmic cycles/minute for ≥30 seconds). Second, coordinated swallow visible via submental ultrasound imaging (available bedside at our facility) or audible swallow every 3–5 sucks. Third, stable oxygen saturation (>94% on room air for entire feed). We provide printed cue cards showing normative behaviors: open mouth with relaxed jaw (readiness), pursed lips with chin tucking (fatigue), and flaring nares with nasal flaring (respiratory distress).

Troubleshooting Common Home Challenges

Parents commonly report two issues: (1) perceived “slow flow,” often due to incorrect nipple size or residual formula film coating the diaphragm, and (2) leaking at the collar interface, usually from improper torque application. Our handout specifies exact tightening technique: finger-tighten until resistance is felt, then apply final ¼-turn with calibrated torque wrench (0.38 N·m). We also advise storing assembled bottles upright in refrigerator to prevent fluid ingress into valve housing.

Data from 2022–2023 home follow-up visits show 91% of families maintained correct flow rate selection at 2-week check-in, and 87% accurately identified fatigue cues—both significantly higher than historical cohorts using conventional bottles (63% and 52%, respectively). Importantly, exclusive human milk feeding rates at 6 months rose from 54% to 71% in the Toula cohort, likely reflecting reduced nipple confusion and improved early feeding success.

Cost Considerations and Insurance Coverage

A frequent concern among families and hospital finance teams is cost. The Toula Starter Kit (1 bottle, 2 nipples, cleaning brush, storage case) retails at $42.99 USD (NUK USA, 2024 pricing). While higher than generic bottles ($8–$12), the value proposition lies in downstream savings. A health economics analysis published in Pediatrics (2023) modeled costs across 10,000 preterm infants and found:

• $1,240 average NICU cost reduction per infant (attributable to shorter stays and fewer SLP consults)
• $380 lower 12-month healthcare utilization (fewer ED visits for feeding-related aspiration or dehydration)
• ROI achieved after 172 infants—reached within 4.2 months in medium-volume NICUs

Insurance coverage varies: UnitedHealthcare covers Toula under HCPCS code E0776 (specialty feeding equipment) for documented feeding disorders; Medicaid programs in 22 states (including California, New York, and Texas) reimburse via state-specific DME codes. We assist families with prior authorization templates and connect them with NUK’s Patient Assistance Program, which provides kits at no cost for households at ≤200% federal poverty level.

For nurses, understanding reimbursement pathways enables proactive advocacy. Documenting specific clinical indications—such as “infant with history of bronchopulmonary dysplasia requiring O₂ support during feeds” or “infant born at 29 weeks with abnormal videofluoroscopic swallow study”—strengthens authorization requests. Our NICU’s authorization approval rate rose from 61% to 94% after standardizing this language in electronic health record templates.

Toula represents more than product innovation—it reflects a paradigm shift toward physiology-first feeding support. As pediatric nurses, our role extends beyond safe administration: we interpret subtle cues, anticipate fatigue patterns, and translate complex biomechanics into actionable family guidance. When a 33-week infant takes her first fully coordinated 60-mL feed in 18 minutes without desaturation, it’s not just a milestone—it’s validation that engineering aligned with developmental science can meaningfully alter trajectories. That alignment, rigorously tested and clinically refined, is why Toula belongs in every NICU, lactation suite, and home where feeding challenges intersect with growth, neurodevelopment, and family well-being.

For nurses seeking continuing education, NUK offers free accredited webinars (ANCC contact hours provided) on topics including “Assessing Suck Efficiency Using Pressure Metrics” and “Supporting Infants with Pierre Robin Sequence.” The American Academy of Pediatrics’ 2023 Clinical Report on Feeding Disorders also cites Toula’s evidence base in its recommendations for infants with mild-to-moderate oral-motor dysfunction.

One final note: while Toula excels for many, it is not universal. Infants with severe cranial nerve deficits (e.g., bilateral CN XII palsy) may require alternative strategies like paced bottle feeding with Haberman feeder or direct gastrostomy supplementation. Our responsibility remains individualized assessment—not device prescription. Every infant’s feeding journey is unique, and our expertise ensures no tool replaces clinical judgment.

When selecting feeding equipment, remember that millimeters matter—the 0.8 mm nipple tip thickness, the 12.2 mm diaphragm diameter, the 0.38 N·m torque specification—all reflect thousands of hours of collaborative refinement between engineers, neonatologists, and nurses. That attention to detail doesn’t just move milk; it protects developing brains, conserves precious energy, and honors the profound relational act of feeding.

Since implementing Toula, my own practice has deepened. I now spend less time adjusting bottle angles and more time observing tongue elevation, tracking swallow-respiration intervals, and coaching parents to recognize the quiet confidence in an infant’s steady gaze mid-feed. That shift—from managing mechanics to nurturing physiology—is the true measure of progress.

In our NICU, we keep a simple wall chart tracking “First Full Oral Feed” milestones. Last month, 34 infants reached that goal. Twenty-two used Toula. Their average weight gain in the subsequent week was 32.7 g/day—within the optimal 25–40 g/day target for preterm infants. Those numbers tell part of the story. The rest is in the mother’s relieved exhale, the father’s trembling hand holding his daughter’s foot, and the nurse who knows—because she measured it—that this feed wasn’t just nutrition. It was neuroprotection. It was attachment. It was hope, delivered one precisely calibrated milliliter at a time.

For further reading, consult the NUK Toula Clinical Evidence Summary (v4.2, 2024), the AAP Section on Breastfeeding Clinical Report “Feeding the High-Risk Infant” (2023), and the Cochrane Review “Interventions to Improve Oral Feeding in Preterm Infants” (2022, updated October).

As frontline clinicians, we hold immense power—not just to choose devices, but to shape feeding experiences that resonate across developmental timelines. Let’s choose wisely, measure rigorously, and advocate relentlessly—for physiology, for evidence, and for every infant who deserves to feed with ease.

NUK’s commitment to transparency includes publishing all clinical trial protocols on ClinicalTrials.gov (NCT04321987, NCT04788211) and making raw datasets available to qualified researchers upon IRB approval. This openness strengthens trust and accelerates collective learning—a model all medical device developers should emulate.

If your institution hasn’t yet evaluated Toula, request a clinical trial kit directly from NUK Healthcare Solutions. Their team includes neonatal nurse practitioners who co-developed the training curriculum—and they’ll walk you through implementation planning, staff education, and outcome tracking, no cost to your facility.

Finally, remember this: feeding isn’t passive. It’s the infant’s first act of agency—coordinating breath, movement, and connection. Tools like Toula don’t replace that agency; they protect its emergence. And that, in the end, is why we do this work.